Ramaprasad Srinivasan, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ramaprasad Srinivasan, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:46 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05665361 · Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)National Cancer Institute (NCI) · recruiting · Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc) · principal investigator
- Ph2NCT02504892 · Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal CancerNational Cancer Institute (NCI) · terminated · Renal Cancer, Birt-Hogg-Dube Syndrome · principal investigator
- Ph1/Ph2NCT02495103 · Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell CarcinomaNational Cancer Institute (NCI) · terminated · Renal Cell Carcinoma, Hereditary Leiomyomatosis, Renal Cell Cancer · principal investigator
- Ph2NCT02019693 · A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell CancerNational Cancer Institute (NCI) · completed · Kidney Cancer · principal investigator
- Ph2NCT01130519 · A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell CancerNational Cancer Institute (NCI) · completed · HLRCC, Sporadic Papillary Renal Cell Cancer · principal investigator
- Ph2NCT01118091 · Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...National Cancer Institute (NCI) · completed · Skin Cancer, Melanoma, Metastatic Melanoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.